Disease model: familial adenomatous polyposis
- 1 August 2001
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 7 (8) , 369-373
- https://doi.org/10.1016/s1471-4914(01)02050-0
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Tumor-associated Apc mutations in Mlh1−/−Apc1638N mice reveal a mutational signature of Mlh1 deficiencyOncogene, 2000
- Mlh1 deficiency enhances several phenotypes of ApcMin/+ miceOncogene, 2000
- Aspirin prevents tumors in a murine model of familial adenomatous polyposisSurgery, 1998
- Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin☆☆☆Gastroenterology, 1998
- Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout miceCarcinogenesis: Integrative Cancer Research, 1997
- Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in ApcΔ716 knockout miceMolecular Carcinogenesis, 1996
- Homozygosity for theMinallele ofApcresults in disruption of mouse development prior to gastrulationDevelopmental Dynamics, 1995
- ApcMin: A mouse model for intestinal and mammary tumorigenesisEuropean Journal Of Cancer, 1995
- Genotype-Phenotype Correlations at the Adenomatous Polyposis Coli (APC) GeneCritical Reviews™ in Oncogenesis, 1995
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992